<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03078569</url>
  </required_header>
  <id_info>
    <org_study_id>wolfson testosterone 1</org_study_id>
    <nct_id>NCT03078569</nct_id>
  </id_info>
  <brief_title>Transdermal Testosterone for Poor Responder Patients Undergoing Controlled Ovarian Stimulation Prior to IVF</brief_title>
  <official_title>Transdermal Testosterone for Poor Responders Undergoing IVF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the efficacy of pre- IVF treatment with transdermal testosterone to
      enhance ovarian response in poor responders.

      a randomized controlled trial with two groups, treatment group with transdermal testosterone
      before IVF treatment and a control group with no treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One of the major challenges of Assisted reproduction technology is treating women with low
      ovarian response,those women achieve very poor pregnancy rate with IVF.

      in recent years there is a focus
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>number of retrieved oocytes</measure>
    <time_frame>2 year</time_frame>
    <description>number of oocytes</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of clinical pregnancies</measure>
    <time_frame>2.5 years</time_frame>
    <description>number of pregnancies with fetal cardiac activity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Infertility, Female</condition>
  <arm_group>
    <arm_group_label>testosterone gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>testosterone gel treatment group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>without testosterone treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Testosterone gel</intervention_name>
    <description>treatment with testosterone gel</description>
    <arm_group_label>testosterone gel</arm_group_label>
    <other_name>testomax</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infertility patients undergoing ART regular menses normal function of thyroid, liver
             and kidney normal BMI (19.3-28.9) without use of any fertility drugs in the previous
             two months

        Exclusion Criteria:

          -  patients with recurrent implantations failure (3 cycles and more) previous ovarian
             surgery uncontrolled medical illness severe endometriosis (stage 3-4) contraindication
             for testosterone use
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>only women under IVF treatment</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>amir Mr shalev, MD</last_name>
    <phone>97235028105</phone>
    <email>amirshalev75@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ariel Mr weissman, Proffesor</last_name>
    <phone>97235028106</phone>
    <email>ariel.weissman@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Wolfson MC</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amir Mr shalev, MD</last_name>
      <phone>97235028105</phone>
      <email>amirshalev75@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2017</study_first_submitted>
  <study_first_submitted_qc>March 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 13, 2017</study_first_posted>
  <last_update_submitted>March 8, 2017</last_update_submitted>
  <last_update_submitted_qc>March 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wolfson Medical Center</investigator_affiliation>
    <investigator_full_name>amir shalev</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Poor responders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Female</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Testosterone</mesh_term>
    <mesh_term>Testosterone enanthate</mesh_term>
    <mesh_term>Testosterone undecanoate</mesh_term>
    <mesh_term>Testosterone 17 beta-cypionate</mesh_term>
    <mesh_term>Methyltestosterone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

